Exploitation of plants for the removal of organics in environmental remediation
T Macek, M Macková, J Káš - Biotechnology advances, 2000 - Elsevier
This review concentrates on the description of various phytoremediation technologies, paying
special attention to removal of organics and the application of in vitro systems for basic …
special attention to removal of organics and the application of in vitro systems for basic …
[HTML][HTML] Phytoextraction of heavy metals: a promising tool for clean-up of polluted environment?
Pollution by heavy metals (HM) represents a serious threat for both the environment and
human health. Due to their elemental character, HM cannot be chemically degraded, and their …
human health. Due to their elemental character, HM cannot be chemically degraded, and their …
Therapeutic application of peptides and proteins: parenteral forever?
Z Antosova, M Mackova, V Kral, T Macek - Trends in biotechnology, 2009 - cell.com
Varied therapeutic peptides and proteins represent a rapidly growing part of marketed drugs
and have an undisputed place alongside other established therapies. Nevertheless, such …
and have an undisputed place alongside other established therapies. Nevertheless, such …
[HTML][HTML] Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
…, S Tauscher-Wisniewski, BE McGill, TA Macek - Nature medicine, 2022 - nature.com
SPR1NT ( NCT03505099 ) was a Phase III, multicenter, single-arm study to investigate the
efficacy and safety of onasemnogene abeparvovec for presymptomatic children with biallelic …
efficacy and safety of onasemnogene abeparvovec for presymptomatic children with biallelic …
[HTML][HTML] Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
…, S Tauscher-Wisniewski, BE McGill, TA Macek - Nature medicine, 2022 - nature.com
Most children with biallelic SMN1 deletions and three SMN2 copies develop spinal muscular
atrophy (SMA) type 2. SPR1NT ( NCT03505099 ), a Phase III, multicenter, single-arm trial, …
atrophy (SMA) type 2. SPR1NT ( NCT03505099 ), a Phase III, multicenter, single-arm trial, …
Genetically modified plants in phytoremediation of heavy metal and metalloid soil and sediment pollution
P Kotrba, J Najmanova, T Macek, T Ruml… - Biotechnology …, 2009 - Elsevier
Phytoremediation to clean up metal- and metalloid-contaminated soil or sediments has gained
increasing attention as environmental friendly and cost effective. Achievements of the last …
increasing attention as environmental friendly and cost effective. Achievements of the last …
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label …
…, H Ouyang, DH Chand, DM Sproule, TA Macek… - The Lancet …, 2021 - thelancet.com
Background Spinal muscular atrophy type 1 is a motor neuron disorder resulting in death or
the need for permanent ventilation by age 2 years. We aimed to evaluate the safety and …
the need for permanent ventilation by age 2 years. We aimed to evaluate the safety and …
Polychlorinated biphenyl (PCB)-degrading bacteria associated with trees in a PCB-contaminated site
…, P Prouzová, M Macková, T Macek… - Applied and …, 2006 - Am Soc Microbiol
The abundance, identities, and degradation abilities of indigenous polychlorinated biphenyl
(PCB)-degrading bacteria associated with five species of mature trees growing naturally in a …
(PCB)-degrading bacteria associated with five species of mature trees growing naturally in a …
Novel roles for genetically modified plants in environmental protection
Transgenic plants of environmental benefit typically consist of plants that either reduce the
input of agrochemicals into the environment or make the biological remediation of …
input of agrochemicals into the environment or make the biological remediation of …
A 3‐week, randomized, placebo‐controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states
…, M Cohen, J Zhao, L Alphs, TA Macek… - Bipolar …, 2009 - Wiley Online Library
… Thomas A Macek … A case of nonspecific ST-T changes and right bundle branch block
in an asenapine-treated patient was considered to be ‘possibly related’ to the study drug. …
in an asenapine-treated patient was considered to be ‘possibly related’ to the study drug. …